| Estradiol | IC50 | 3.6 [1] |
| Estradiol | Ki | 0.01 [1] |
| Raloxifene | IC50 | 12.0 [1] |
| Genistein | IC50 | 9.7 [1], 10.0 [2], 83.0 [3], 395.0 [4] |
| Genistein | Ki | 0.59 [1], 24.0 [2] |
| Tamoxifen | IC50 | 1000.0 [1], 1660.0 [2] |
| Tamoxifen | Ki | 0.51 [1] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 43.0 [1], 45.0 [2] |
| (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)-phenyl)-2-phenylbut-1-en-1-yl)phenol | IC50 | 1.0 [1], 20.0 [2], 26.1 [3], 100.0 [4] |
| (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)-phenyl)-2-phenylbut-1-en-1-yl)phenol | Ki | 0.01 [1], 1.7 [2], 3.16 [3] |
| Daidzein | IC50 | 303.0 [1], 1100.0 [2], 1200.0 [3], 2800.0 [4] |
| Daidzein | Ki | 300.0 [1] |
| Fulvestrant | IC50 | 3.8 [1], 7.0 [2], 8.4 [3], 21.0 [4], 44.1 [5] |
| Fulvestrant | Ki | 1.39 [1] |
| 2-Phenyl-1-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-1,2,3,4-tetrahydroisoquinolin-6-ol | IC50 | 289.07 [1] |
| 2-Phenyl-1-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-1,2,3,4-tetrahydroisoquinolin-6-ol | IC50 | 22.2 [1], 165.96 [2], 166.0 [3], 291.0 [4], 291.07 [5] |
| Afimoxifene | IC50 | 21.0 [1], 32.0 [2] |
| Afimoxifene | Ki | 0.16 [1], 0.5 [2] |
| Lasofoxifene | IC50 | 1.8 [1], 13.0 [2], 24.0 [3] |
| Erteberel | Ki | 0.17 [1], 0.19 [2] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 64.0 [1] |
| 2-(4-Fluorophenyl)-1-methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 92.0 [1], 92.04 [2], 316.96 [3], 317.0 [4] |
| 2-(4-Fluorophenyl)-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 82.0 [1], 82.04 [2], 204.0 [3], 204.17 [4] |
| 1-Methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-2-(3-propan-2-ylphenyl)-3,4-dihydroisoquinolin-6-ol | IC50 | 492.0 [1], 492.04 [2], 1104.08 [3], 1105.0 [4] |
| 1-Methyl-2-(4-methylphenyl)-1-[4-(2-piperidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 420.73 [1], 421.0 [2], 486.0 [3], 486.41 [4] |
| 2-(4-Chlorophenyl)-1-methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 396.0 [1], 396.28 [2], 552.0 [3], 552.08 [4] |
| 2-(3-Hydroxyphenyl)-1-methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 46.99 [1], 47.0 [2], 304.0 [3], 304.09 [4] |
| 2-(3-Chlorophenyl)-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 105.93 [1], 106.0 [2], 272.0 [3], 272.27 [4] |
| 2-(3-Chlorophenyl)-1-methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 158.85 [1], 159.0 [2], 283.79 [3], 284.0 [4] |
| 1-Methyl-2-phenyl-1-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-1,2,3,4-tetrahydroisoquinolin-6-ol | IC50 | 82.99 [1], 83.0 [2], 103.99 [3], 104.0 [4] |
| 2-(3-Fluorophenyl)-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 123.0 [1], 123.03 [2], 198.0 [3], 198.15 [4] |
| 2-(3-Hydroxyphenyl)-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 33.0 [1], 33.04 [2], 190.0 [3], 190.11 [4] |
| 1-Methyl-2-(4-methylphenyl)-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 354.0 [1], 447.71 [2], 448.0 [3] |
| 2-(4-Chlorophenyl)-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 302.0 [1], 530.88 [2], 531.0 [3] |
| 1-{4-[2-(Azepan-1-yl)ethoxy]phenyl}-1-methyl-2-phenyl-1,2,3,4-tetrahydroisoquinolin-6-ol | IC50 | 79.98 [1], 80.0 [2], 199.99 [3], 200.0 [4] |
| 1-Methyl-2-(4-propan-2-ylphenyl)-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 1972.42 [1], 1974.0 [2], 4974.0 [3], 4977.37 [4] |
| 1-Methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-2-(4-propan-2-ylphenyl)-3,4-dihydroisoquinolin-6-ol | IC50 | 3687.0 [1], 3689.78 [2], 4775.29 [3], 4776.0 [4] |
| 1-Methyl-2-phenyl-1-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-1,2,3,4-tetrahydroisoquinolin-6-ol | IC50 | 82.99 [1], 83.0 [2], 226.99 [3], 227.0 [4] |
| 2-[3-(Dimethylamino)phenyl]-1-methyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydroisoquinolin-6-ol | IC50 | 2202.93 [1], 2205.0 [2], 2971.67 [3], 2974.0 [4] |
| (2R,3S)-3-(4-Hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 52.0 [1], 287.0 [2], 3876.0 [3] |
| Testosterone | IC50 | 10000.0 [1] |
| Diethylstilbestrol | IC50 | 4.0 [1], 610.0 [2] |
| Diethylstilbestrol | Ki | 0.63 [1] |
| Mifepristone | IC50 | 812.0 [1] |
| Mifepristone | Ki | 750.0 [1], 2876.0 [2] |
| Raloxifene hydrochloride | IC50 | 43.0 [1], 260.0 [2], 341.0 [3] |
| Coumestrol | IC50 | 2.0 [1], 18.6 [2] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-[2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy]phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 87.0 [1], 161.0 [2] |
| 2-(5-Hydroxy-naphthalen-1-YL)-1,3-benzooxazol-6-OL | IC50 | 5.0 [1] |
| 3-(6-Hydroxy-naphthalen-2-YL)-benzo[D]isooxazol-6-OL | IC50 | 1.0 [1], 1.4 [2] |
| (2S,3R)-3-(3-Hydroxyphenyl)-2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 37.0 [1], 38.0 [2], 40.1 [3] |
| (3Ar,4S,9bS)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | Ki | 0.47 [1], 1.54 [2] |
| 2,4-Diisobutylamino-6-isopentylpyrimidine | IC50 | 1000000.0 [1] |
| 2,4-Diisobutylamino-6-isopentylpyrimidine | Ki | 2800.0 [1], 1000000.0 [2] |
| (2S,3R)-3-(3-Hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 115.0 [1], 157.4 [2] |
| (2R,3S)-3-(4-Hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-7-ol | IC50 | 44.4 [1], 45.0 [2], 238.8 [3] |
| 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile | IC50 | 550.0 [1], 6300.0 [2], 15000.0 [3] |
| (E)-3-[2-(4-Hydroxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-6-yl]prop-2-enoic acid | IC50 | 104.0 [1], 10000.0 [2] |
| Prednisolone | IC50 | 10000.0 [1], 100000.0 [2] |
| Estrone | IC50 | 31.0 [1], 540.0 [2] |
| Ethinyl estradiol | IC50 | 8.1 [1], 17.78 [2] |
| Spironolactone | IC50 | 20000.0 [1] |
| Emodin | IC50 | 5200.0 [1] |
| Emodin | Ki | 1500.0 [1] |
| Androstenediol | IC50 | 9.9 [1], 10.0 [2] |
| Bazedoxifene | IC50 | 3.8 [1], 85.0 [2] |
| Arzoxifene | IC50 | 66.3 [1], 240.0 [2] |
| Estetrol | Ki | 19.0 [1] |
| Lasofoxifene hydrochloride | IC50 | 13.0 [1], 24.0 [2] |
| Prinaberel | IC50 | 5.0 [1] |
| 2,6-Dihydroxyanthraquinone | IC50 | 2400.0 [1] |
| 2,6-Dihydroxyanthraquinone | Ki | 690.0 [1] |
| 7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-OL | IC50 | 2.0 [1] |
| (3As,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | Ki | 0.44 [1] |
| Emodin-8-glucoside | IC50 | 62000.0 [1] |
| Emodin-8-glucoside | Ki | 18000.0 [1] |
| 6-(4-Hydroxyphenyl)-2-naphthol | IC50 | 16.0 [1], 16.3 [2] |
| (E)-3-[4-[(E)-1-(4-Hydroxyphenyl)-2-phenylbut-1-enyl]phenyl]prop-2-enoic acid | IC50 | 3.0 [1] |
| (E)-3-[4-[(E)-1-(4-Hydroxyphenyl)-2-phenylbut-1-enyl]phenyl]prop-2-enoic acid | Ki | 10.0 [1] |
| 3-(4-Hydroxy-phenyl)-4H-chromen-7-ol | IC50 | 680.0 [1] |
| 6-(2-Hydroxyphenyl)-2-naphthol | IC50 | 2000.0 [1] |
| 4-Bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol | IC50 | 1.8 [1] |
| 2-(4-Hydroxy-phenyl)benzofuran-5-OL | IC50 | 6.0 [1] |
| 4-Bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-fluoren-3-one | IC50 | 1.8 [1] |
| 4-Chloro-6-(6-hydroxy-1,2-benzoxazol-3-yl)benzene-1,3-diol | IC50 | 2.0 [1] |
| 5-Hydroxy-2-(4-hydroxy-phenyl)-benzooxazole-7-carbonitrile | IC50 | 6.0 [1] |
| 4,4'-(5,7-Bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2,3-diyl)diphenol | IC50 | 600.0 [1] |
| 4,4'-(5,7-Bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2,3-diyl)diphenol | Ki | 48.0 [1] |
| 2-(4-Hydroxyphenyl)benzo[d]oxazol-6-ol | IC50 | 50.0 [1] |
| 2-(4-Hydroxy-phenyl)-7-vinyl-benzooxazol-5-ol | IC50 | 3.5 [1] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-[(2S)-2-pyrrolidin-1-ylpropoxy]phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 45.0 [1] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-[(2R)-2-pyrrolidin-1-ylpropoxy]phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 71.0 [1] |
| 2-(6-Hydroxynaphthalen-1-yl)benzo[d]oxazol-6-ol | IC50 | 3.0 [1] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-[2-[(3S)-3-methylpyrrolidin-1-yl]ethoxy]phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 50.0 [1] |
| 2-Naphthalen-1-yl-benzooxazol-6-ol | IC50 | 1050.0 [1] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-[(2S)-2-[(3R)-3-methylpyrrolidin-1-yl]propoxy]phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 52.0 [1] |
| 2-(5-Bromo-6-hydroxynaphthalen-1-yl)benzo[d]oxazol-6-ol | IC50 | 134.0 [1] |
| 6-Butyl-2,4-dipropylaminopyrimidine | Ki | 16000.0 [1], 1000000.0 [2] |
| 5-Fluoro-2-(6-hydroxynaphthalen-1-yl)benzo[d]oxazol-6-ol | IC50 | 46.0 [1] |